Hims & Hers Health, INC Form 4 insider transactions

Chief Operating Officer of Hims & Hers Health, Inc., Nader Kabbani, reports the acquisition of 216,333 Restricted Stock Units (RSUs) tied to Class A Common Stock.

Hims & Hers Health's CFO, Oluyemi Okupe, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on May 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Mohamed Elshenawy, Chief Technology Officer of Hims & Hers Health, Inc., was granted 1,036,339 Restricted Stock Units (RSUs) on May 12, 2025, vesting over a four-year period.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on May 12, 2025, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,235 shares of Class A Common Stock on May 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock at a price of $30.19 per share on April 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on April 28 and 29, 2025, according to a Form 4 filing with the SEC.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on April 21, 2025, according to a Form 4 filing with the SEC.

Irene Becklund, PAO of Hims & Hers Health, sold 2,936 shares of Class A Common Stock at $26.49 per share on April 22, 2025, under a pre-arranged 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. on April 16, 2025, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported selling shares of Class A Common Stock on March 3, 2025, and April 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on April 15, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on April 9, 2025, according to a Form 4 filing with the SEC.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports exercising stock options and acquiring Class A Common Stock on April 4, 2025.

Irene Becklund, PAO of Hims & Hers Health, Inc., reports selling 2,203 shares of Class A Common Stock on April 3, 2025, at a price of $28.78 per share.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on April 2, 2025, according to a Form 4 filing with the SEC.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options on March 31, 2025, acquiring 13,460 shares of Class A Common Stock.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock at a price of $27.77 per share on March 31, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on March 26, 2025, according to a Form 4 filing with the SEC.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 23,118 shares of Class A Common Stock at an average price of $32.4066 on March 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director and Chief Medical Officer Patrick Harrison Carroll reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on March 14 and March 17-18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and disposal of restricted stock units to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Director Christiane Pendarvis reports acquisition of Hims & Hers Health Class A Common Stock through vesting of Restricted Stock Units.

Irene Becklund, PAO of Hims & Hers Health, reports the vesting and sale of Class A Common Stock and Restricted Stock Units.

Chief Commercial Officer Michael Chi reports the vesting and settlement of Restricted Stock Units (RSUs) and associated tax withholding, resulting in changes to his beneficial ownership of Hims & Hers Health, Inc. stock.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on March 14, 2025.

CEO Andrew Dudum reports the acquisition of 306,406 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc. on March 11, 2025, according to a Form 4 filing.